CardioCommand MissionMore efficient healthcare. As the inventor of DinamapTM 20 years ago, I believed technology could make a real clinical contribution in the noninvasive monitoring of arterial blood pressure. Today, technology must also enable more efficient healthcare delivery. CardioCommand has pioneered a new class of noninvasive technology that can diagnose, monitor and treat the heart.

More at-risk patients. Meeting a growing needCardioCommand provides clinicians with safer and faster treatment and diagnostic options for achieving optimum heart rate. Its technology combines safe heart rate control with breakthrough monitoring parameters to help minimize patient risk from known or unrecognized heart disease in both acute care and diagnostic settings.

Noninvasive, safe and efficient. The Esophageal Window to the Heart

Predictable heart rate control. TAPSCOPE TM . . . for perioperative hemodynamic management

100 patients comparing TAPSTRESSTM and Mayo standard dobutamine stress echo protocolRESULTS: TAPSTRESSTM dobutamine -minutes: test+recovery 9.6 29.0 -achieved target HR 98 % 89 % -symptoms/dysrhythmias few more -wall motion concordance good good-labor intensity of test less greater

*Lee, Pellikka, et al, Nonexercise Stress Transthoracic Echocardiography: Transesophageal Atrial Pacing versus Dobutamine Stress. JACC, 1999; 33:506-11Reimbursable, out-of-hospital testing. TAPSTRESS TM . . . for non-exercise stress echocardiography

No anesthesia, no intracardiac catheters. TAPCATHTM . . . for electrophysiology & cardioversion

And the promise of a new approach.

Worlds leader in transesophageal technology. About CardioCommand CardioCommand has 9 products with FDA PMA approval for US distribution and 29 issued US and International patents in the areas of transesophaeal pacing and cardioversion. Over 200 scientific articles have investigated & validated transesophageal technology and applications CardioCommand, Inc. operated as ARZCO Medical Systems, Inc. from 1994 until 1998 CardioCommands corporate headquarters are located in Tampa, Florida, under the direction of Maynard (Mike) Ramsey, MD, PhD